1. Therapy for early COVID-19, a critical need;Kim;JAMA,2020
2. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19);McCullough;Rev Cardiovasc Med,2020
3. Bamlanivimab and Etesevimab Fact Sheet for Health Care Providers Emergency Use Authorization. Eli Lilly, Indianapolis, IN. Revised 03/2021. Available at: http://pi.lilly.com/eua/bam-and-ete-eua-factsheet-hcp.pdf. Accessed April 9, 2021.
4. REGEN-COV Fact Sheet for Health Care Providers Emergency Use Authorization. Regeneron pharmaceuticals, Inc., Tarrytown, NY. Revised 03/2021. Available at: https://www.fda.gov/media/145611/download. Accessed April 9, 2021.
5. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies;Chen;Nat Med,2021